Document is current
Any future updates will be listed below
-
Authors
Choe, Hannah
DeFilipp, Zachariah https://orcid.org/0000-0002-7994-8974
- License Information
-
More Information
Article History
Received: 19 June 2025
Revised: 10 October 2025
Accepted: 28 October 2025
First Online: 13 November 2025
Competing interests
: HC has received research funding from National Institutes of Health National Cancer Institute; has received honoraria from MJH Life Sciences; has received travel support from Actinium Pharmaceuticals; and has served as a consultant and board of directors/advisory committee member and received equipment, materials, or drugs to her institution from Incyte Corporation. ZD has served as a consultant for Incyte Corporation, Inhibrx, MorphoSys, Ono Pharmaceuticals, PharmaBiome AG, and Sanofi; has received honoraria from Incyte Corporation and MorphoSys; and has received research funding from Incyte Corporation, Regimmune, and Taiho Oncology.
